Progression of kidney disease in type 2 diabetes - Beyond blood pressure control: An observational study

BMC Nephrology

Volumn 6, Issue , 2005, Pages

  Leehey, David J ^a,b   Kramer, Holly J ^a,b,c   Daoud, Tarek M ^a,b   Chatha, Maninder P ^a,b   Isreb, Majd A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; PROTEIN; SERUM ALBUMIN;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOALBUMINEMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PROTEINURIA;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CHRONIC DISEASE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; HYPOALBUMINEMIA; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEINURIA;

EID: 23244453709     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-6-8     Document Type: Article

References (37)

1. American Diabetes Association: Nephropathy in Diabetes. Clinical Practice Recommendations. Diabetes Care 2004, 27(Suppl 1):S79-83.
2. Ueda H, Ishimura E, Shoji T, et al.: Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 2003, 26:1530-1534.
3. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving H-H: Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004, 66:1596-1605.
4. Bakris GL: The importance of blood pressure control in the patient with diabetes. Am J Med 2004, 116(Suppl 5A):30S-38S.
5. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, Classification, and Stratification. Am J Kidney Dis 2002, 39:S76-92.
6. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) 1982, 285(6343):685-688.
7. Parving HH, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983, 1(8335):1175-1179.
8. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) 1986, 293(6545):471-474.
9. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) 1987, 294(6585):1443-1447.
10. Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 1988, 297(6656):1086-1091.
11. Sawicki PT, Muhlhauser I, Didjurgeit U, Berger M: Effects of intensification of antihypertensive care in diabetic nephropathy. J Diabetes Complications 1995, 9(4):315-317.
12. Trocha AK, Schmidtke C, Didjurgeit U, et al.: Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study. J Hypertens 1999, 17(10):1497-1503.
13. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713.
14. Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ: Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis 1999, 34:809-817.
15. Estacio RO, Jeffers BW, Gifford N, Schrier RW: Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000, 23(Suppl 2):B54-64.
16. Keane WF, Brenner BM, De Zeeuw D, RENAAL Study Investigators, et al.: The risk of developing end-stage renal disease in patients with type2 diabetes and nephropathy: The RENAAL Study. Kidney Int 2003, 63:1499-1507.
17. Bakris GL, Weir MR, Shanifar S, RENAAL Study Group, et al.: Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003, 163:1555-1565.
18. Middleton JP, Lewis J, for the Collaborative Study Group: Predictors of renal outcome in type 2 diabetic nephropathy [abstract]. J Am Soc Nephrol 2002, 13:249-250.
19. Tomlinson JW, Owen KR, Close CF: Treating hypertension in diabetic nephropathy. Diabetes Care 2003, 26:1802-1805.
20. Dillon JJ: The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis 1993, 22:798-802.
21. Yokoyama H, Tomonaga O, Hirayama M, et al.: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting- enzyme inhibitors in NIDDM patients. Diabetologia 1997, 40:405-411.
22. Breyer JA, Bain P, Evans JK, et al.: Predictors of progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 1996, 50:1651-1658.
23. Gall M-A, Nielsen FS, Smidt UM, et al.: The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1993, 36:1071-1078.
24. Nelson RG, Bennett PH, Beck GJ, et al.: Development and progression of renal disease in Pima Indians with non-insulindependent DM. N Engl J Med 1996, 335:1636-1642.
25. Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC: The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999, 22:743-751.
26. Massy ZA, Khoa TN, Lacour B, Deschamps-Latshca B, Man NK, Jungers P: Dyslipidaemia and progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 1999, 14:2392-2397.
27. Ruggenenti P, Remuzzi G: The role of protein traffic in the progression of renal diseases. Annu Rev Med 2000, 51:315-327.
28. Sarnak MJ, Poindexter A, Wang SR, et al.: Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 2002, 62:2208-2215.
29. Stenvinkel P, Heimburger O, Paultre F, et al.: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1899-1911.
30. Kim SB, Yang WS, Park JS: Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients. Perit Dial Int 1999, 19(S2):S144-149.
31. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002, 62:1524-1538.
32. Witko-Sarat V, Friedlander M, Nguyen Khoa T, et al.: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998, 161:2524-2532.
33. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA: Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD, and hemodialysis patients. Kidney Int 1994, 45:890-896.
34. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, DeJong PE, DeZeeuw D: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003, 63:654-661.
35. Menon V, Wang X, Greene T, et al.: Relationship between Creactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 2003, 42:44-52.
36. Navarro JF, Mora C, Macia M, Garcia J: Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 2003, 42:53-61.
37. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM: Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005, 16:459-466.